{"id":"W4402986892","doi":"10.1200/op.2024.20.10_suppl.399","title":"US real-world utilization and outcomes of darolutamide, enzalutamide, and apalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC): DEAR-EXT study.","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Enzalutamide; Prostate cancer; Medicine; Oncology; Internal medicine; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001085113,0.0002483204,0.000620077,0.0003364735,0.0001706657,0.00007770711,0.00006375678,0.0001019019,0.00004715663],"category_scores_gemma":[0.0006859825,0.0001891608,0.0000637914,0.0004371342,0.0002581193,0.0004858937,0.00007388338,0.0002942386,0.000004531865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003673848,"about_ca_system_score_gemma":0.0009643735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001850763,"about_ca_topic_score_gemma":0.003616682,"domain_scores_codex":[0.9979125,0.0002626732,0.0005606573,0.0005412157,0.0003566841,0.0003662653],"domain_scores_gemma":[0.9966702,0.002343115,0.0002376907,0.0002396548,0.0003369693,0.0001724012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01789062,0.003576985,0.6893902,0.004094591,0.005359274,0.001655714,0.01323815,0.00007395625,0.01677212,0.003509202,0.002878076,0.2415611],"study_design_scores_gemma":[0.01207308,0.007840842,0.8473822,0.0003724643,0.004485107,0.0001913471,0.007298682,0.003124354,0.001748846,0.0006199713,0.1144163,0.0004468515],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773732,0.007571158,0.00007646018,0.008149787,0.0003160805,0.00377726,0.0001875412,0.00007770844,0.002470745],"genre_scores_gemma":[0.9833084,0.00712068,0.002846168,0.0003521704,0.00008265943,0.00069742,0.00006300365,0.00005149217,0.00547806],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2411142,"threshold_uncertainty_score":0.7713755,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07738946556382287,"score_gpt":0.4619376274253936,"score_spread":0.3845481618615708,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}